Approval · Notice of Compliance 18508 · 2016
YONDELIS: Notice of Compliance 18508
Issued September 23, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18508
- Date
- September 23, 2016
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph with safety information as recommended in health canada's advisement letter dated may 12, 2016
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| YONDELIS | 02351528 | Marketed |
Medicinal ingredients
- TRABECTEDIN 1 MG per VIAL